カテゴリ： GlobalInfoResearch, 世界, 産業機械/建設

世界の選択的グルココルチコイド受容体モジュレーター市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Selective Glucocorticoid Receptor Modulator Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO17013）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO17013
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：産業機器
■ ページ数：108
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の選択的グルココルチコイド受容体モジュレーター市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

選択的グルココルチコイド受容体モジュレーター市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の選択的グルココルチコイド受容体モジュレーターの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

選択的グルココルチコイド受容体モジュレーター市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・選択的アンドロゲン受容体モジュレーター、選択的エストロゲン受容体モジュレーター、選択的プロゲステロン受容体モジュレーター

用途別セグメントは次のように区分されます。
・病院、診療所、外来手術センター、その他

世界の選択的グルココルチコイド受容体モジュレーター市場の主要な市場プレーヤーは以下のとおりです。
・Johnson & Johnson、Pfizer、Roche Holding、Novartis、Merck、Sanofi、AbbVie、Takeda Pharmaceutical Company、GlaxoSmithKline plc、Teva Pharmaceuticals

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、選択的グルココルチコイド受容体モジュレーター製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な選択的グルココルチコイド受容体モジュレーターメーカーの企業概要、2019年～2022年までの選択的グルココルチコイド受容体モジュレーターの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な選択的グルココルチコイド受容体モジュレーターメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別選択的グルココルチコイド受容体モジュレーターの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの選択的グルココルチコイド受容体モジュレーターの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での選択的グルココルチコイド受容体モジュレーター市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および選択的グルココルチコイド受容体モジュレーターの産業チェーンを掲載しています。
・第13、14、15章では、選択的グルココルチコイド受容体モジュレーターの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 選択的グルココルチコイド受容体モジュレーターの概要
- 種類別分析（2017年vs2021年vs2028年）：選択的アンドロゲン受容体モジュレーター、選択的エストロゲン受容体モジュレーター、選択的プロゲステロン受容体モジュレーター
- 用途別分析（2017年vs2021年vs2028年）：病院、診療所、外来手術センター、その他
- 世界の選択的グルココルチコイド受容体モジュレーター市場規模・予測
- 世界の選択的グルココルチコイド受容体モジュレーター生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Johnson & Johnson、Pfizer、Roche Holding、Novartis、Merck、Sanofi、AbbVie、Takeda Pharmaceutical Company、GlaxoSmithKline plc、Teva Pharmaceuticals
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：選択的アンドロゲン受容体モジュレーター、選択的エストロゲン受容体モジュレーター、選択的プロゲステロン受容体モジュレーター
・用途別分析2017年-2028年：病院、診療所、外来手術センター、その他
・選択的グルココルチコイド受容体モジュレーターの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・選択的グルココルチコイド受容体モジュレーターのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・選択的グルココルチコイド受容体モジュレーターのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・選択的グルココルチコイド受容体モジュレーターの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・選択的グルココルチコイド受容体モジュレーターの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Selective Glucocorticoid Receptor Modulator market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Selective Glucocorticoid Receptor Modulator market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Selective Glucocorticoid Receptor Modulator global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Selective Androgen Receptor Modulators segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Selective Glucocorticoid Receptor Modulator include Johnson & Johnson, Pfizer, Roche Holding, Novartis, and Merck, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Selective Glucocorticoid Receptor Modulator market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Selective Androgen Receptor Modulators
Selective Estrogen Receptor Modulators
Selective Progesterone Receptor Modulators
Market segment by Application can be divided into
Hospitals
Clinics
Ambulatory Surgical Centers
Others
The key market players for global Selective Glucocorticoid Receptor Modulator market are listed below:
Johnson & Johnson
Pfizer
Roche Holding
Novartis
Merck
Sanofi
AbbVie
Takeda Pharmaceutical Company
GlaxoSmithKline plc
Teva Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Selective Glucocorticoid Receptor Modulator product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Selective Glucocorticoid Receptor Modulator, with price, sales, revenue and global market share of Selective Glucocorticoid Receptor Modulator from 2019 to 2022.
Chapter 3, the Selective Glucocorticoid Receptor Modulator competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Selective Glucocorticoid Receptor Modulator breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Selective Glucocorticoid Receptor Modulator market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Selective Glucocorticoid Receptor Modulator.
Chapter 13, 14, and 15, to describe Selective Glucocorticoid Receptor Modulator sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Selective Glucocorticoid Receptor Modulator Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Selective Glucocorticoid Receptor Modulator Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Selective Androgen Receptor Modulators
1.2.3 Selective Estrogen Receptor Modulators
1.2.4 Selective Progesterone Receptor Modulators
1.3 Market Analysis by Application
1.3.1 Overview: Global Selective Glucocorticoid Receptor Modulator Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Global Selective Glucocorticoid Receptor Modulator Market Size & Forecast
1.4.1 Global Selective Glucocorticoid Receptor Modulator Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Selective Glucocorticoid Receptor Modulator Sales in Volume (2017-2028)
1.4.3 Global Selective Glucocorticoid Receptor Modulator Price (2017-2028)
1.5 Global Selective Glucocorticoid Receptor Modulator Production Capacity Analysis
1.5.1 Global Selective Glucocorticoid Receptor Modulator Total Production Capacity (2017-2028)
1.5.2 Global Selective Glucocorticoid Receptor Modulator Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Selective Glucocorticoid Receptor Modulator Market Drivers
1.6.2 Selective Glucocorticoid Receptor Modulator Market Restraints
1.6.3 Selective Glucocorticoid Receptor Modulator Trends Analysis
2 Manufacturers Profiles
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson Selective Glucocorticoid Receptor Modulator Product and Services
2.1.4 Johnson & Johnson Selective Glucocorticoid Receptor Modulator Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Selective Glucocorticoid Receptor Modulator Product and Services
2.2.4 Pfizer Selective Glucocorticoid Receptor Modulator Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Roche Holding
2.3.1 Roche Holding Details
2.3.2 Roche Holding Major Business
2.3.3 Roche Holding Selective Glucocorticoid Receptor Modulator Product and Services
2.3.4 Roche Holding Selective Glucocorticoid Receptor Modulator Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Selective Glucocorticoid Receptor Modulator Product and Services
2.4.4 Novartis Selective Glucocorticoid Receptor Modulator Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business
2.5.3 Merck Selective Glucocorticoid Receptor Modulator Product and Services
2.5.4 Merck Selective Glucocorticoid Receptor Modulator Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business
2.6.3 Sanofi Selective Glucocorticoid Receptor Modulator Product and Services
2.6.4 Sanofi Selective Glucocorticoid Receptor Modulator Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 AbbVie
2.7.1 AbbVie Details
2.7.2 AbbVie Major Business
2.7.3 AbbVie Selective Glucocorticoid Receptor Modulator Product and Services
2.7.4 AbbVie Selective Glucocorticoid Receptor Modulator Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Takeda Pharmaceutical Company
2.8.1 Takeda Pharmaceutical Company Details
2.8.2 Takeda Pharmaceutical Company Major Business
2.8.3 Takeda Pharmaceutical Company Selective Glucocorticoid Receptor Modulator Product and Services
2.8.4 Takeda Pharmaceutical Company Selective Glucocorticoid Receptor Modulator Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 GlaxoSmithKline plc
2.9.1 GlaxoSmithKline plc Details
2.9.2 GlaxoSmithKline plc Major Business
2.9.3 GlaxoSmithKline plc Selective Glucocorticoid Receptor Modulator Product and Services
2.9.4 GlaxoSmithKline plc Selective Glucocorticoid Receptor Modulator Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Teva Pharmaceuticals
2.10.1 Teva Pharmaceuticals Details
2.10.2 Teva Pharmaceuticals Major Business
2.10.3 Teva Pharmaceuticals Selective Glucocorticoid Receptor Modulator Product and Services
2.10.4 Teva Pharmaceuticals Selective Glucocorticoid Receptor Modulator Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Selective Glucocorticoid Receptor Modulator Breakdown Data by Manufacturer
3.1 Global Selective Glucocorticoid Receptor Modulator Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Selective Glucocorticoid Receptor Modulator Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Selective Glucocorticoid Receptor Modulator
3.4 Market Concentration Rate
3.4.1 Top 3 Selective Glucocorticoid Receptor Modulator Manufacturer Market Share in 2021
3.4.2 Top 6 Selective Glucocorticoid Receptor Modulator Manufacturer Market Share in 2021
3.5 Global Selective Glucocorticoid Receptor Modulator Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Selective Glucocorticoid Receptor Modulator Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Selective Glucocorticoid Receptor Modulator Market Size by Region
4.1.1 Global Selective Glucocorticoid Receptor Modulator Sales in Volume by Region (2017-2028)
4.1.2 Global Selective Glucocorticoid Receptor Modulator Revenue by Region (2017-2028)
4.2 North America Selective Glucocorticoid Receptor Modulator Revenue (2017-2028)
4.3 Europe Selective Glucocorticoid Receptor Modulator Revenue (2017-2028)
4.4 Asia-Pacific Selective Glucocorticoid Receptor Modulator Revenue (2017-2028)
4.5 South America Selective Glucocorticoid Receptor Modulator Revenue (2017-2028)
4.6 Middle East and Africa Selective Glucocorticoid Receptor Modulator Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Selective Glucocorticoid Receptor Modulator Sales in Volume by Type (2017-2028)
5.2 Global Selective Glucocorticoid Receptor Modulator Revenue by Type (2017-2028)
5.3 Global Selective Glucocorticoid Receptor Modulator Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Selective Glucocorticoid Receptor Modulator Sales in Volume by Application (2017-2028)
6.2 Global Selective Glucocorticoid Receptor Modulator Revenue by Application (2017-2028)
6.3 Global Selective Glucocorticoid Receptor Modulator Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Selective Glucocorticoid Receptor Modulator Sales by Type (2017-2028)
7.2 North America Selective Glucocorticoid Receptor Modulator Sales by Application (2017-2028)
7.3 North America Selective Glucocorticoid Receptor Modulator Market Size by Country
7.3.1 North America Selective Glucocorticoid Receptor Modulator Sales in Volume by Country (2017-2028)
7.3.2 North America Selective Glucocorticoid Receptor Modulator Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Selective Glucocorticoid Receptor Modulator Sales by Type (2017-2028)
8.2 Europe Selective Glucocorticoid Receptor Modulator Sales by Application (2017-2028)
8.3 Europe Selective Glucocorticoid Receptor Modulator Market Size by Country
8.3.1 Europe Selective Glucocorticoid Receptor Modulator Sales in Volume by Country (2017-2028)
8.3.2 Europe Selective Glucocorticoid Receptor Modulator Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Selective Glucocorticoid Receptor Modulator Sales by Type (2017-2028)
9.2 Asia-Pacific Selective Glucocorticoid Receptor Modulator Sales by Application (2017-2028)
9.3 Asia-Pacific Selective Glucocorticoid Receptor Modulator Market Size by Region
9.3.1 Asia-Pacific Selective Glucocorticoid Receptor Modulator Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Selective Glucocorticoid Receptor Modulator Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Selective Glucocorticoid Receptor Modulator Sales by Type (2017-2028)
10.2 South America Selective Glucocorticoid Receptor Modulator Sales by Application (2017-2028)
10.3 South America Selective Glucocorticoid Receptor Modulator Market Size by Country
10.3.1 South America Selective Glucocorticoid Receptor Modulator Sales in Volume by Country (2017-2028)
10.3.2 South America Selective Glucocorticoid Receptor Modulator Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Selective Glucocorticoid Receptor Modulator Sales by Type (2017-2028)
11.2 Middle East & Africa Selective Glucocorticoid Receptor Modulator Sales by Application (2017-2028)
11.3 Middle East & Africa Selective Glucocorticoid Receptor Modulator Market Size by Country
11.3.1 Middle East & Africa Selective Glucocorticoid Receptor Modulator Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Selective Glucocorticoid Receptor Modulator Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Selective Glucocorticoid Receptor Modulator and Key Manufacturers
12.2 Manufacturing Costs Percentage of Selective Glucocorticoid Receptor Modulator
12.3 Selective Glucocorticoid Receptor Modulator Production Process
12.4 Selective Glucocorticoid Receptor Modulator Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Selective Glucocorticoid Receptor Modulator Typical Distributors
13.3 Selective Glucocorticoid Receptor Modulator Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Selective Glucocorticoid Receptor Modulator Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Selective Glucocorticoid Receptor Modulator Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 4. Johnson & Johnson Major Business
Table 5. Johnson & Johnson Selective Glucocorticoid Receptor Modulator Product and Services
Table 6. Johnson & Johnson Selective Glucocorticoid Receptor Modulator Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Selective Glucocorticoid Receptor Modulator Product and Services
Table 10. Pfizer Selective Glucocorticoid Receptor Modulator Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Roche Holding Basic Information, Manufacturing Base and Competitors
Table 12. Roche Holding Major Business
Table 13. Roche Holding Selective Glucocorticoid Receptor Modulator Product and Services
Table 14. Roche Holding Selective Glucocorticoid Receptor Modulator Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Novartis Basic Information, Manufacturing Base and Competitors
Table 16. Novartis Major Business
Table 17. Novartis Selective Glucocorticoid Receptor Modulator Product and Services
Table 18. Novartis Selective Glucocorticoid Receptor Modulator Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Merck Basic Information, Manufacturing Base and Competitors
Table 20. Merck Major Business
Table 21. Merck Selective Glucocorticoid Receptor Modulator Product and Services
Table 22. Merck Selective Glucocorticoid Receptor Modulator Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Sanofi Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi Major Business
Table 25. Sanofi Selective Glucocorticoid Receptor Modulator Product and Services
Table 26. Sanofi Selective Glucocorticoid Receptor Modulator Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. AbbVie Basic Information, Manufacturing Base and Competitors
Table 28. AbbVie Major Business
Table 29. AbbVie Selective Glucocorticoid Receptor Modulator Product and Services
Table 30. AbbVie Selective Glucocorticoid Receptor Modulator Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Takeda Pharmaceutical Company Basic Information, Manufacturing Base and Competitors
Table 32. Takeda Pharmaceutical Company Major Business
Table 33. Takeda Pharmaceutical Company Selective Glucocorticoid Receptor Modulator Product and Services
Table 34. Takeda Pharmaceutical Company Selective Glucocorticoid Receptor Modulator Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 36. GlaxoSmithKline plc Major Business
Table 37. GlaxoSmithKline plc Selective Glucocorticoid Receptor Modulator Product and Services
Table 38. GlaxoSmithKline plc Selective Glucocorticoid Receptor Modulator Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 40. Teva Pharmaceuticals Major Business
Table 41. Teva Pharmaceuticals Selective Glucocorticoid Receptor Modulator Product and Services
Table 42. Teva Pharmaceuticals Selective Glucocorticoid Receptor Modulator Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Selective Glucocorticoid Receptor Modulator Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 44. Global Selective Glucocorticoid Receptor Modulator Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Selective Glucocorticoid Receptor Modulator, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Selective Glucocorticoid Receptor Modulator Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Selective Glucocorticoid Receptor Modulator Production Site of Key Manufacturer
Table 48. Selective Glucocorticoid Receptor Modulator New Entrant and Capacity Expansion Plans
Table 49. Selective Glucocorticoid Receptor Modulator Mergers & Acquisitions in the Past Five Years
Table 50. Global Selective Glucocorticoid Receptor Modulator Sales by Region (2017-2022) & (K Units)
Table 51. Global Selective Glucocorticoid Receptor Modulator Sales by Region (2023-2028) & (K Units)
Table 52. Global Selective Glucocorticoid Receptor Modulator Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Selective Glucocorticoid Receptor Modulator Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Selective Glucocorticoid Receptor Modulator Sales by Type (2017-2022) & (K Units)
Table 55. Global Selective Glucocorticoid Receptor Modulator Sales by Type (2023-2028) & (K Units)
Table 56. Global Selective Glucocorticoid Receptor Modulator Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Selective Glucocorticoid Receptor Modulator Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Selective Glucocorticoid Receptor Modulator Price by Type (2017-2022) & (US$/Unit)
Table 59. Global Selective Glucocorticoid Receptor Modulator Price by Type (2023-2028) & (US$/Unit)
Table 60. Global Selective Glucocorticoid Receptor Modulator Sales by Application (2017-2022) & (K Units)
Table 61. Global Selective Glucocorticoid Receptor Modulator Sales by Application (2023-2028) & (K Units)
Table 62. Global Selective Glucocorticoid Receptor Modulator Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Selective Glucocorticoid Receptor Modulator Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Selective Glucocorticoid Receptor Modulator Price by Application (2017-2022) & (US$/Unit)
Table 65. Global Selective Glucocorticoid Receptor Modulator Price by Application (2023-2028) & (US$/Unit)
Table 66. North America Selective Glucocorticoid Receptor Modulator Sales by Country (2017-2022) & (K Units)
Table 67. North America Selective Glucocorticoid Receptor Modulator Sales by Country (2023-2028) & (K Units)
Table 68. North America Selective Glucocorticoid Receptor Modulator Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Selective Glucocorticoid Receptor Modulator Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Selective Glucocorticoid Receptor Modulator Sales by Type (2017-2022) & (K Units)
Table 71. North America Selective Glucocorticoid Receptor Modulator Sales by Type (2023-2028) & (K Units)
Table 72. North America Selective Glucocorticoid Receptor Modulator Sales by Application (2017-2022) & (K Units)
Table 73. North America Selective Glucocorticoid Receptor Modulator Sales by Application (2023-2028) & (K Units)
Table 74. Europe Selective Glucocorticoid Receptor Modulator Sales by Country (2017-2022) & (K Units)
Table 75. Europe Selective Glucocorticoid Receptor Modulator Sales by Country (2023-2028) & (K Units)
Table 76. Europe Selective Glucocorticoid Receptor Modulator Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Selective Glucocorticoid Receptor Modulator Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Selective Glucocorticoid Receptor Modulator Sales by Type (2017-2022) & (K Units)
Table 79. Europe Selective Glucocorticoid Receptor Modulator Sales by Type (2023-2028) & (K Units)
Table 80. Europe Selective Glucocorticoid Receptor Modulator Sales by Application (2017-2022) & (K Units)
Table 81. Europe Selective Glucocorticoid Receptor Modulator Sales by Application (2023-2028) & (K Units)
Table 82. Asia-Pacific Selective Glucocorticoid Receptor Modulator Sales by Region (2017-2022) & (K Units)
Table 83. Asia-Pacific Selective Glucocorticoid Receptor Modulator Sales by Region (2023-2028) & (K Units)
Table 84. Asia-Pacific Selective Glucocorticoid Receptor Modulator Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Selective Glucocorticoid Receptor Modulator Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Selective Glucocorticoid Receptor Modulator Sales by Type (2017-2022) & (K Units)
Table 87. Asia-Pacific Selective Glucocorticoid Receptor Modulator Sales by Type (2023-2028) & (K Units)
Table 88. Asia-Pacific Selective Glucocorticoid Receptor Modulator Sales by Application (2017-2022) & (K Units)
Table 89. Asia-Pacific Selective Glucocorticoid Receptor Modulator Sales by Application (2023-2028) & (K Units)
Table 90. South America Selective Glucocorticoid Receptor Modulator Sales by Country (2017-2022) & (K Units)
Table 91. South America Selective Glucocorticoid Receptor Modulator Sales by Country (2023-2028) & (K Units)
Table 92. South America Selective Glucocorticoid Receptor Modulator Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Selective Glucocorticoid Receptor Modulator Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Selective Glucocorticoid Receptor Modulator Sales by Type (2017-2022) & (K Units)
Table 95. South America Selective Glucocorticoid Receptor Modulator Sales by Type (2023-2028) & (K Units)
Table 96. South America Selective Glucocorticoid Receptor Modulator Sales by Application (2017-2022) & (K Units)
Table 97. South America Selective Glucocorticoid Receptor Modulator Sales by Application (2023-2028) & (K Units)
Table 98. Middle East & Africa Selective Glucocorticoid Receptor Modulator Sales by Region (2017-2022) & (K Units)
Table 99. Middle East & Africa Selective Glucocorticoid Receptor Modulator Sales by Region (2023-2028) & (K Units)
Table 100. Middle East & Africa Selective Glucocorticoid Receptor Modulator Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Selective Glucocorticoid Receptor Modulator Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Selective Glucocorticoid Receptor Modulator Sales by Type (2017-2022) & (K Units)
Table 103. Middle East & Africa Selective Glucocorticoid Receptor Modulator Sales by Type (2023-2028) & (K Units)
Table 104. Middle East & Africa Selective Glucocorticoid Receptor Modulator Sales by Application (2017-2022) & (K Units)
Table 105. Middle East & Africa Selective Glucocorticoid Receptor Modulator Sales by Application (2023-2028) & (K Units)
Table 106. Selective Glucocorticoid Receptor Modulator Raw Material
Table 107. Key Manufacturers of Selective Glucocorticoid Receptor Modulator Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Selective Glucocorticoid Receptor Modulator Typical Distributors
Table 111. Selective Glucocorticoid Receptor Modulator Typical Customers
List of Figures
Figure 1. Selective Glucocorticoid Receptor Modulator Picture
Figure 2. Global Selective Glucocorticoid Receptor Modulator Revenue Market Share by Type in 2021
Figure 3. Selective Androgen Receptor Modulators
Figure 4. Selective Estrogen Receptor Modulators
Figure 5. Selective Progesterone Receptor Modulators
Figure 6. Global Selective Glucocorticoid Receptor Modulator Revenue Market Share by Application in 2021
Figure 7. Hospitals
Figure 8. Clinics
Figure 9. Ambulatory Surgical Centers
Figure 10. Others
Figure 11. Global Selective Glucocorticoid Receptor Modulator Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Selective Glucocorticoid Receptor Modulator Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Selective Glucocorticoid Receptor Modulator Sales (2017-2028) & (K Units)
Figure 14. Global Selective Glucocorticoid Receptor Modulator Price (2017-2028) & (US$/Unit)
Figure 15. Global Selective Glucocorticoid Receptor Modulator Production Capacity (2017-2028) & (K Units)
Figure 16. Global Selective Glucocorticoid Receptor Modulator Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Selective Glucocorticoid Receptor Modulator Market Drivers
Figure 18. Selective Glucocorticoid Receptor Modulator Market Restraints
Figure 19. Selective Glucocorticoid Receptor Modulator Market Trends
Figure 20. Global Selective Glucocorticoid Receptor Modulator Sales Market Share by Manufacturer in 2021
Figure 21. Global Selective Glucocorticoid Receptor Modulator Revenue Market Share by Manufacturer in 2021
Figure 22. Selective Glucocorticoid Receptor Modulator Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Selective Glucocorticoid Receptor Modulator Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Selective Glucocorticoid Receptor Modulator Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Selective Glucocorticoid Receptor Modulator Sales Market Share by Region (2017-2028)
Figure 26. Global Selective Glucocorticoid Receptor Modulator Revenue Market Share by Region (2017-2028)
Figure 27. North America Selective Glucocorticoid Receptor Modulator Revenue (2017-2028) & (USD Million)
Figure 28. Europe Selective Glucocorticoid Receptor Modulator Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Selective Glucocorticoid Receptor Modulator Revenue (2017-2028) & (USD Million)
Figure 30. South America Selective Glucocorticoid Receptor Modulator Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Selective Glucocorticoid Receptor Modulator Revenue (2017-2028) & (USD Million)
Figure 32. Global Selective Glucocorticoid Receptor Modulator Sales Market Share by Type (2017-2028)
Figure 33. Global Selective Glucocorticoid Receptor Modulator Revenue Market Share by Type (2017-2028)
Figure 34. Global Selective Glucocorticoid Receptor Modulator Price by Type (2017-2028) & (US$/Unit)
Figure 35. Global Selective Glucocorticoid Receptor Modulator Sales Market Share by Application (2017-2028)
Figure 36. Global Selective Glucocorticoid Receptor Modulator Revenue Market Share by Application (2017-2028)
Figure 37. Global Selective Glucocorticoid Receptor Modulator Price by Application (2017-2028) & (US$/Unit)
Figure 38. North America Selective Glucocorticoid Receptor Modulator Sales Market Share by Type (2017-2028)
Figure 39. North America Selective Glucocorticoid Receptor Modulator Sales Market Share by Application (2017-2028)
Figure 40. North America Selective Glucocorticoid Receptor Modulator Sales Market Share by Country (2017-2028)
Figure 41. North America Selective Glucocorticoid Receptor Modulator Revenue Market Share by Country (2017-2028)
Figure 42. United States Selective Glucocorticoid Receptor Modulator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Selective Glucocorticoid Receptor Modulator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Selective Glucocorticoid Receptor Modulator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Selective Glucocorticoid Receptor Modulator Sales Market Share by Type (2017-2028)
Figure 46. Europe Selective Glucocorticoid Receptor Modulator Sales Market Share by Application (2017-2028)
Figure 47. Europe Selective Glucocorticoid Receptor Modulator Sales Market Share by Country (2017-2028)
Figure 48. Europe Selective Glucocorticoid Receptor Modulator Revenue Market Share by Country (2017-2028)
Figure 49. Germany Selective Glucocorticoid Receptor Modulator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Selective Glucocorticoid Receptor Modulator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Selective Glucocorticoid Receptor Modulator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Selective Glucocorticoid Receptor Modulator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Selective Glucocorticoid Receptor Modulator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Selective Glucocorticoid Receptor Modulator Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Selective Glucocorticoid Receptor Modulator Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Selective Glucocorticoid Receptor Modulator Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Selective Glucocorticoid Receptor Modulator Revenue Market Share by Region (2017-2028)
Figure 58. China Selective Glucocorticoid Receptor Modulator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Selective Glucocorticoid Receptor Modulator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Selective Glucocorticoid Receptor Modulator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Selective Glucocorticoid Receptor Modulator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Selective Glucocorticoid Receptor Modulator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Selective Glucocorticoid Receptor Modulator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Selective Glucocorticoid Receptor Modulator Sales Market Share by Type (2017-2028)
Figure 65. South America Selective Glucocorticoid Receptor Modulator Sales Market Share by Application (2017-2028)
Figure 66. South America Selective Glucocorticoid Receptor Modulator Sales Market Share by Country (2017-2028)
Figure 67. South America Selective Glucocorticoid Receptor Modulator Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Selective Glucocorticoid Receptor Modulator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Selective Glucocorticoid Receptor Modulator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Selective Glucocorticoid Receptor Modulator Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Selective Glucocorticoid Receptor Modulator Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Selective Glucocorticoid Receptor Modulator Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Selective Glucocorticoid Receptor Modulator Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Selective Glucocorticoid Receptor Modulator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Selective Glucocorticoid Receptor Modulator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Selective Glucocorticoid Receptor Modulator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Selective Glucocorticoid Receptor Modulator Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Selective Glucocorticoid Receptor Modulator in 2021
Figure 79. Manufacturing Process Analysis of Selective Glucocorticoid Receptor Modulator
Figure 80. Selective Glucocorticoid Receptor Modulator Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • グルココルチコイドの世界市場 2022年-2026年
  • 世界のアデノシン受容体A3市場2022年：市場規模予測（～2028年）
  • 世界の選択的レーザー焼結プリンター市場2022年：市場規模予測（～2028年）
  • レーザー変調器のグローバル市場展望 2023年-2029年：強度変調器、位相変調器、ユニバーサル変調器
  • 世界のトロンボポエチン受容体アゴニスト市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO17013 )"世界の選択的グルココルチコイド受容体モジュレーター市場2022年：市場規模予測（～2028年）" (英文：Global Selective Glucocorticoid Receptor Modulator Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。